Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis

被引：25

作者：

Schramm, C ^{[1
]}

Lohse, AW ^{[1
]}

机构：

[1] Univ Klinikum Hamburg Eppendorf, Med Klin 1, Hamburg, Germany

来源：

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY | 2005年 / 28卷 / 02期

关键词：

auto-antibody; immunogenetics; biliary epithelial cells; T-cell receptor; lymphocytes;

D O I：

10.1385/CRIAI:28:2:105

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 [免疫学];

摘要：

Approximately 18 % of patients with auto-immune liver disease present with features characteristic of a second auto-immune liver disease. These cases have been termed "overlap syndromes." The pathogenesis of overlap syndromes is poorly understood, and few data are available regarding the clinical characteristics and outcome of this disease. Therefore, a consensus on the definition of overlap syndromes has not been reached. A common genetic background between auto-immune hepatitis (AIH) and its overlap with primary biliary cirrhosis (PBC) or primary sclerosing cholangitis (PSC) might confer susceptibility to a more inflammatory phenotype, probably requiring combined immunosuppressive treatment. This article focuses on the prevalence, diagnosis, and treatment of the overlap syndrome of AIH and PBC or PSC.

引用

页码：105 / 114

页数：10

共 67 条

[1]

Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome [J].

Abdo, AA ;

Bain, VG ;

Kichian, K ;

Lee, SS .

HEPATOLOGY, 2002, 36 (06) :1393-1399

[2]

International Autoimmune Hepatitis Group Report:: review of criteria for diagnosis of autoimmune hepatitis [J].

Alvarez, E ;

Berg, PA ;

Bianchi, FB ;

Bianchi, L ;

Burroughs, AK ;

Cancado, EL ;

Chapman, RW ;

Cooksley, WGE ;

Czaja, AJ ;

Desmet, VJ ;

Donaldson, RT ;

Eddleston, ALWF ;

Fainboim, L ;

Heathcote, J ;

Homberg, JC ;

Hoofnagle, JH ;

Kakumu, S ;

Krawitt, EL ;

Mackay, IR ;

MacSween, RNM ;

Maddrey, WC ;

Manns, MP ;

McFarlane, IG ;

zum Büschenfelde, KHM ;

Mieli-Vergani, G ;

Nakanuma, Y ;

Nishioka, M ;

Penner, E ;

Porta, G ;

Portmann, BC ;

Reed, WD ;

Rodes, J ;

Schalm, SW ;

Scheuer, PJ ;

Schrumpf, E ;

Seki, T ;

Toda, G ;

Tsuji, T ;

Tygstrup, N ;

Vergani, D ;

Zeniya, M .

JOURNAL OF HEPATOLOGY, 1999, 31 (05) :929-938

[3]

Primary sclerosing cholangitis [J].

Angulo, P ;

Lindor, KD .

HEPATOLOGY, 1999, 30 (01) :325-332

[4]

Small-duct primary sclerosing cholangitis: A long-term follow-up study [J].

Angulo, P ;

Maor-Kendler, Y ;

Lindor, KD .

HEPATOLOGY, 2002, 35 (06) :1494-1500

[5]

Serum autoantibodies in patients with primary sclerosing cholangitis [J].

Angulo, P ;

Peter, JB ;

Gershwin, ME ;

DeSotel, CK ;

Shoenfeld, Y ;

Ahmed, AEE ;

Lindor, KD .

JOURNAL OF HEPATOLOGY, 2000, 32 (02) :182-187

[6]

Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics [J].

Baeres, M ;

Herkel, J ;

Czaja, AJ ;

Wies, I ;

Kanzler, S ;

Cancado, ELR ;

Porta, G ;

Nishioka, M ;

Simon, T ;

Daehnrich, C ;

Schlumberger, W ;

Galle, PR ;

Lohse, AW .

GUT, 2002, 51 (02) :259-264

[7]

PRIMARY SCLEROSING CHOLANGITIS WITH NORMAL SERUM ALKALINE-PHOSPHATASE ACTIVITY [J].

BALASUBRAMANIAM, K ;

WIESNER, RH ;

LARUSSO, NF .

GASTROENTEROLOGY, 1988, 95 (05) :1395-1398

[8]

Autoimmune hepatitis and its variant syndromes [J].

Ben-Ari, Z ;

Czaja, AJ .

GUT, 2001, 49 (04) :589-594

[9]

Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis [J].

Boberg, KM ;

Fausa, O ;

Haaland, T ;

Holter, E ;

Mellbye, OJ ;

Spurkland, A ;

Schrumpf, E .

HEPATOLOGY, 1996, 23 (06) :1369-1376

[10]

Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients [J].

Boberg, KM ;

Egeland, T ;

Schrumpf, E .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (09) :991-995

← 1 2 3 4 5 6 7 →